AMPK-activation by Metformin in FSGS: AMP-FSGS

Clinical trial NCT06090227 · RECRUITING

Trial details

NCT number: NCT06090227
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Focal Segmental Glomerulosclerosis

Start date: 2023-12-14
Primary completion: 2027-11-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.